Pharmacokinetics, Tissue Distribution and Excretion of Coumarin Components from Psoralea corylifolia L. in Rats

被引:43
作者
Feng, Liang [1 ]
Wang, Ling [2 ]
Jiang, Xuehua [2 ]
机构
[1] ChengDu Univ TCM, Dept Pharm, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, W China Ctr Med Sci, Dept Pharm, Chengdu 610041, Peoples R China
关键词
Psoralen; Isopsoralen; Wistar rats; Pharmacokinetics; Distribution; Excretion;
D O I
10.1007/s12272-010-0206-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Coumarin components from Psoralea corylifolia L. are novel drugs in which psoralen and isopsoralen are the active components. The pharmacokinetics, tissue distribution and excretion of the two compounds were studied by liquid chromatography-tandem mass spectrometry after intravenous administration to Wistar rats. The elimination half-lives of psoralen and isopsoralen were 4.88 and 5.35 h. After dosing, the area under the curves of the tissues decreased in the following order: liver > lung > heart > kidney > spleen > brain for psoralen; and kidney > lung > liver > heart > spleen > brain for isopsoralen. After dosing, 51.27% of psoralen and 56.25% of isopsoralen were excreted as prototype, and urine was the major excretion route. In addition, the pharmacokinetics of psoralen and isopsoralen after oral administration to Wistar rats were also studied. The elimination half-lives of psoralen and isopsoralen were 4.13 and 5.56 h, and their relative bioavailabilities were 61.45% and 70.35%. Overall, the results show that coumarin components from P. corylifolia L. have high oral bioavailability, they are rapidly and widely distributed into tissues after intravenous administration, but they are slowly cleared and excreted.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 9 条
[1]   Inhibitory effect of bupleuri radix saponins on adhesion of some solid tumor cells and relation to hemolytic action: Screening of 232 herbal drugs for anti-cell adhesion [J].
Ahn, BZ ;
Yoon, YD ;
Lee, YH ;
Kim, BH ;
Sok, DE .
PLANTA MEDICA, 1998, 64 (03) :220-224
[2]   Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets [J].
Ciaravino, V ;
McCullough, T ;
Dayan, AD .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2001, 20 (10) :533-550
[3]  
Guo LQ, 2004, ACTA PHARMACOL SIN, V25, P129
[4]  
HUANG X, 1991, J 4 MIL MED U, V3, P210
[5]  
HUANG X, 1991, J 4 MIL MED U, V5, P349
[6]  
Jia L, 2001, ACTA BOT BOREALI-OCC, V21, P579
[7]  
LUO ZD, 1998, ACTA PHARMACOL SIN, V16, P705
[8]   BIOPHARMACEUTICS, PHARMACOKINETICS AND PHARMACOLOGY OF PSORALENS [J].
STOLK, LML ;
SIDDIQUI, AH .
GENERAL PHARMACOLOGY, 1988, 19 (05) :649-653
[9]   Antiplatelet flavonoids from seeds of Psoralea corylifolia [J].
Tsai, WJ ;
Hsin, WC ;
Chen, CC .
JOURNAL OF NATURAL PRODUCTS, 1996, 59 (07) :671-672